What reinfections mean for COVID-19.

Akiko Iwasaki

Erratum issuedAbstract readComment

In one paragraph

Article in The Lancet. Infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 125 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it

0cells of the map it votes in

125citing papers in PubMed, 8 pooled it

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 8 syntheses or guidelines pooled it.

Convalescent plasma for people with COVID-19: a living systematic review.The Cochrane database of systematic reviews · 2023
Pooled it
Convalescent plasma for people with COVID-19: a living systematic review.The Cochrane database of systematic reviews · 2023
Pooled it
Hyperimmune immunoglobulin for people with COVID-19.The Cochrane database of systematic reviews · 2023
Pooled it
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery - a comprehensive systematic review and meta-analysis.Pathogens and global health · 2022
Pooled it
Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis.Chinese medical journal · 2022
Pooled it
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.The Cochrane database of systematic reviews · 2021
Pooled it
Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases.Viruses · 2021
Pooled it
Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review.PloS one · 2021
Pooled it
Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation.The Lancet. Microbe · 2023
Trial
High Post-Infection Protection after COVID-19 among Healthcare Workers: A Population-Level Observational Study.Iranian journal of medical sciences · 2024
Observational
Low Risk of SARS-CoV-2 Reinfection for Fully or Boosted mRNA Vaccinated Subjects in Sicily: A Population-Based Study Using Real-World Data.Vaccines · 2023
Article
COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine.Reports (MDPI) · 2023
Review
Wastewater-based modeling, reconstruction, and prediction for COVID-19 outbreaks in Hungary caused by highly immune evasive variants.Water research · 2023
Article
Correlations of demographic factors and hygiene factors with face mask wearing during the COVID-19 pandemic and suggestion for future research: A cross-sectional study of adults in Malaysia.Journal of public health research · 2023
Article
Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents.The Journal of pediatrics · 2023
Article
Fear and Stigma of COVID-19 Reinfection Scale (FSoCOVID-19RS): New Scale Development and Validation.Healthcare (Basel, Switzerland) · 2023
Article
Jump-Drop Adjusted Prediction of Cumulative Infected Cases Using the Modified SIS Model.Annals of data science · 2023
Article
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data.PloS one · 2023
Observational
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study.Wellcome open research · 2023
Article
Association of Results of Four Lateral Flow Antibody Tests with Subsequent SARS-CoV-2 Infection.Microbiology spectrum · 2022
Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

Commented on by
Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection.2021
Comment on
Genomic evidence for reinfection with SARS-CoV-2: a case study.2021
Erratum issued
Correction to Lancet Infect Dis 2020; published online Oct 12. https://doi.org/10.1016/S1473-3099(20)30783-0.2021

5 · Who and what money

Authors and funding

1 author.

Akiko IwasakiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Molecular Cellular and Developmental Biology, Yale University, New Haven, CT 06510, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: akiko.iwasaki@yale.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2GenomicsHumansRecurrenceReinfection

Identifiers

PMID33058796

DOI10.1016/S1473-3099(20)30783-0

PMCPMC7550040

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.